Physician profile
Jay R Patel
NPI 1518147495
$59,973.36
in general payments reported to CMS, 2019-2025
28 companies · $19K in 2025
The $19K reported for 2025 was more than what 92% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $174 · 2021: $408 · 2022: $1,470 · 2023: $15K · 2024: $23K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $43K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,375 · Food and Beverage: $4,216 · Travel and Lodging: $3,744 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $42,993.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,375.00 |
| Food and Beverage | $4,216.43 |
| Travel and Lodging | $3,743.66 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $50,109.41 | 2020-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Abbott Laboratories | $7,166.98 | 2021-2024 | Freestyle Libre 3 |
| Insulet Corporation | $313.96 | 2022-2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $286.86 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $253.59 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $252.27 | 2022-2023 | Jardiance, Mounjaro, Humulin |
| Cequr Corporation | $214.62 | 2024-2025 | Cequr Simplicity |
| Beta Bionics, INC. | $170.76 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Novo Nordisk INC | $152.69 | 2022-2023 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $145.47 | 2022 | |
| Sequel Med Tech, LLC | $139.49 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $129.29 | 2022 | |
| Amarin Pharma, INC. | $106.52 | 2019 | |
| Medtronic Minimed, INC. | $79.57 | 2019-2020 | |
| Globus Medical, INC. | $55.50 | 2025 | Senza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $54.45 | 2022-2025 | Minimed 780g |
| Amgen INC. | $54.26 | 2022-2024 | Tepezza, Evenity, Prolia |
| Amryt Pharma Holdings LTD | $52.87 | 2023 | Mycapssa |
| Nevro Corp. | $48.13 | 2020 | |
| Mannkind Corporation | $36.44 | 2022 | |
| Corcept Therapeutics | $36.43 | 2023 | Korlym |
| Boston Scientific Corporation | $23.10 | 2020 | |
| Allergan, INC. | $16.40 | 2020 | |
| Abbvie INC. | $16.17 | 2021 | |
| Antares Pharma, INC. | $15.93 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.22 | 2025 | Evkeeza |
| Horizon Therapeutics Plc | $13.73 | 2023 | Tepezza |
| Abiomed | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.